logo
In Full: ECB's Guindos on Inflation, Financial Stability

In Full: ECB's Guindos on Inflation, Financial Stability

Bloomberg22-05-2025

European Central Bank Vice President Luis de Guindos discusses the ECB's Financial Stability Review, in which it warned that heightened investor concern over the riskiness of US assets could further jolt the world's financial system. Talking with Bloomberg's Alexander Weber on May 22 in Frankfurt, Guindos also comments on the outlook for inflation, monetary policy and the euro-zone economy. (Source: Bloomberg)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com
Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Yahoo

time22 minutes ago

  • Yahoo

Aurora Cannabis says ‘second instance of misinformation' posted on Investing.com

Aurora Cannabis (ACB) announced that it has become aware of 'a second instance of misinformation' posted on news website On June 18, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. 'The company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated 'with the support of AI' and reviewed by an editor. The company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the company. Any information regarding material corporate transactions will be announced directly by the company to the market as soon as it is appropriate to do so,' Aurora stated. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ACB: Disclaimer & DisclosureReport an Issue Aurora Cannabis Reports Record Revenue and Growth Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics Aurora Cannabis denies acquisition of MedLeaf Therapeutics Morning Movers: Circle rises following regulatory framework for stablecoins Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RBI Opted For Outsized Rate Cut to Boost Growth, Minutes Show
RBI Opted For Outsized Rate Cut to Boost Growth, Minutes Show

Bloomberg

time23 minutes ago

  • Bloomberg

RBI Opted For Outsized Rate Cut to Boost Growth, Minutes Show

India's central bank governor said that front-loaded interest rate cut and the cash boost would support the Indian economy amid global uncertainties, minutes of the central bank's monetary policy meeting showed Friday. The Reserve Bank of India's rate-setting panel delivered an out-sized 50 basis points interest rate cut earlier this month and announced a liquidity measures for the banking system. The six-member monetary policy committee also simultaneously shifted its policy stance to neutral from accommodative, indicating limited room for further easing.

Report: Wirtz successfully completes medical checks with Liverpool
Report: Wirtz successfully completes medical checks with Liverpool

Yahoo

time23 minutes ago

  • Yahoo

Report: Wirtz successfully completes medical checks with Liverpool

Germany's Florian Wirtz (L) and France's Manu Kone stand on the pitch after the UEFA Nations League soccer match between Germany and France at Stuttgart Arena. Federico Gambarini/dpa Bayer Leverkusen playmaker Florian Wirtz has successfully completed medical checks with Liverpool, broadcasters Sky reported on Friday. He's now expected to sign a deal with the Premier League champions until 2030. Advertisement The deal for the young forward could be worth up to €150 million ($172.74 million) including bonuses, making Wirtz the most expensive signing in Bundesliga and Premier League history. Only Paris Saint-German's moves for Neymar and Kylian Mbappe have ever carried a higher transfer fee. The Germany international had been a major target for top European clubs, including Leverkusen's Bundesliga rivals Bayern Munich.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store